000022541 000__ 01625cam\a22003855i\4500
000022541 001__ 22541
000022541 003__ SzGeWIPO
000022541 005__ 20210318104901.0
000022541 008__ 981028s1998\\\\enk\\\\\r\\\\u000\0\eng\d
000022541 035__ $$a(wipo)(CD )98-1833
000022541 035__ $$a(OCoLC)1161219992
000022541 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000022541 043__ $$ae------
000022541 084__ $$a72$$qGB
000022541 1001_ $$aCunningham, Ralph,$$eauthor.
000022541 24510 $$aRunning with the regulators :$$bpharmaceutical regulators cannot keep everyone happy. The ethical companies think they are too eager to let generic competitors into the market; generics think they are not eager enough /$$cRalph Cunningham.
000022541 264_1 $$aLondon [England] :$$bEuromoney Institutional Investor PLC,$$c1998.
000022541 300__ $$a1 volume ([15] pages) ;$$c[28] cm.
000022541 336__ $$atext$$btxt$$2rdacontent
000022541 337__ $$aunmediated$$bn$$2rdamedia
000022541 338__ $$avolume$$bnc$$2rdacarrier
000022541 4901_ $$aManaging Intellectual Property ;$$v1998 No 82 pages 16-31
000022541 650_0 $$aTrademarks$$zUnited Kingdom.
000022541 650_0 $$aPatents$$zEurope.
000022541 650_0 $$aIntellectual property$$zEurope.
000022541 650_4 $$aPATENTS : PATENTABILITY : PHARMACEUTICAL PRODUCTS, PATENTS IN MEDICINE, BIOLOGY
000022541 650_4 $$aPHARMACEUTICAL COMPANIES : EUROPEAN REGULATION
000022541 650_4 $$aPHARMACEUTICALS : BRAND NAMES
000022541 650_4 $$aGENERIC DRUGS : PATENT PROTECTION
000022541 651_0 $$aEurope$$xCommerce$$xLaw and legislation.
000022541 830_0 $$aManaging Intellectual Property ;$$v1998 No 82 pages 16-31.
000022541 903__ $$v1$$aMANAGING INTELLECTUAL PROPERTY
000022541 942__ $$cART$$2ddc
000022541 952__ $$w2006-11-03$$p1998-1833$$r0.00$$u35256$$bMAIN$$10$$kGB 72$$v1998-10-28$$zLIBRARY$$70
000022541 980__ $$aBIB
000022541 999__ $$c24500$$d24500